The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy.

Saved in:
Bibliographic Details
Title: The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy.
Authors: Wang LD; 1] Department of Pathology, Joslin Diabetes Center, Boston, MA, USA [2] Harvard Stem Cell Institute, Cambridge, MA, USA [3] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA [4] Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA, USA [5] Department of Medicine, Boston Children's Hospital, Boston, MA, USA., Rao TN; 1] Department of Pathology, Joslin Diabetes Center, Boston, MA, USA [2] Harvard Stem Cell Institute, Cambridge, MA, USA [3] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Rowe RG; 1] Harvard Stem Cell Institute, Cambridge, MA, USA [2] Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA, USA [3] Department of Medicine, Boston Children's Hospital, Boston, MA, USA [4] Manton Center for Orphan Disease Research, Boston, MA, USA [5] Howard Hughes Medical Institute, Boston, MA, USA., Nguyen PT; 1] Department of Pathology, Joslin Diabetes Center, Boston, MA, USA [2] Harvard Stem Cell Institute, Cambridge, MA, USA [3] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Sullivan JL; 1] Department of Pathology, Joslin Diabetes Center, Boston, MA, USA [2] Harvard Stem Cell Institute, Cambridge, MA, USA [3] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Pearson DS; 1] Harvard Stem Cell Institute, Cambridge, MA, USA [2] Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA, USA [3] Department of Medicine, Boston Children's Hospital, Boston, MA, USA [4] Manton Center for Orphan Disease Research, Boston, MA, USA [5] Howard Hughes Medical Institute, Boston, MA, USA [6] Medical Scientist Training Program, Harvard Medical School, Boston, MA, USA., Doulatov S; 1] Harvard Stem Cell Institute, Cambridge, MA, USA [2] Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA, USA [3] Department of Medicine, Boston Children's Hospital, Boston, MA, USA [4] Manton Center for Orphan Disease Research, Boston, MA, USA [5] Howard Hughes Medical Institute, Boston, MA, USA., Wu L; 1] Department of Pediatrics and Internal Medicine, Children's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA [2] Organ Transplant Center, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Lindsley RC; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [2] Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA., Zhu H; Department of Pediatrics and Internal Medicine, Children's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Daley GQ; 1] Harvard Stem Cell Institute, Cambridge, MA, USA [2] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA [3] Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA, USA [4] Department of Medicine, Boston Children's Hospital, Boston, MA, USA [5] Manton Center for Orphan Disease Research, Boston, MA, USA [6] Howard Hughes Medical Institute, Boston, MA, USA [7] Medical Scientist Training Program, Harvard Medical School, Boston, MA, USA [8] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Wagers AJ; 1] Department of Pathology, Joslin Diabetes Center, Boston, MA, USA [2] Harvard Stem Cell Institute, Cambridge, MA, USA [3] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA [4] Howard Hughes Medical Institute, Boston, MA, USA.
Source: Leukemia [Leukemia] 2015 Jun; Vol. 29 (6), pp. 1320-30. Date of Electronic Publication: 2015 Feb 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/leu.2015.19